NDC 51167-122

ORKAMBI

Lumacaftor And Ivacaftor

ORKAMBI is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Vertex Pharmaceuticals Incorporated. The primary component is Ivacaftor; Lumacaftor.

Product ID51167-122_2412d19f-9f31-49f3-a7f9-f44db330fcf7
NDC51167-122
Product TypeHuman Prescription Drug
Proprietary NameORKAMBI
Generic NameLumacaftor And Ivacaftor
Dosage FormGranule
Route of AdministrationORAL
Marketing Start Date2022-09-02
Marketing CategoryNDA /
Application NumberNDA211358
Labeler NameVertex Pharmaceuticals Incorporated
Substance NameIVACAFTOR; LUMACAFTOR
Active Ingredient Strength94 mg/1; mg/1
Pharm ClassesChloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inducers [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 51167-122-01

56 PACKET in 1 CARTON (51167-122-01) > 1 GRANULE in 1 PACKET
Marketing Start Date2022-09-02
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ORKAMBI" or generic name "Lumacaftor And Ivacaftor"

NDCBrand NameGeneric Name
51167-122ORKAMBIlumacaftor and ivacaftor
51167-500ORKAMBIlumacaftor and ivacaftor
51167-700ORKAMBIlumacaftor and ivacaftor
51167-809ORKAMBIlumacaftor and ivacaftor
51167-900ORKAMBIlumacaftor and ivacaftor

Trademark Results [ORKAMBI]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ORKAMBI
ORKAMBI
86399751 4828608 Live/Registered
Vertex Pharmaceuticals Incorporated
2014-09-19
ORKAMBI
ORKAMBI
86179790 4822946 Live/Registered
Vertex Pharmaceuticals Incorporated
2014-01-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.